Dec 17, 2025 04:31AM Canaccord Genuity Reiterates Buy Rating on Artivion Inc. (AORT)

Nov 7, 2025 06:11AM Artivion Inc. (AORT) PT Raised to $50 at Oppenheimer

Nov 7, 2025 04:06AM Artivion Inc. (AORT) PT Raised to $58 at Needham

Nov 6, 2025 04:15PM Artivion (AORT) Tops Q3 EPS by 13c ; Offers Guidance

Oct 13, 2025 08:01AM Artivion presents positive AMDS trial data at European cardiac surgery meeting

Oct 10, 2025 04:09AM Citizens Lifts Artivion (AORT) PT to $47 on Pipeline Strength, Growth Outlook

Sep 29, 2025 04:29PM Artivion agrees to purchase two Austin buildings for $20.5 million

Sep 29, 2025 06:33AM Artivion Inc. (AORT) PT Raised to $50 at Canaccord Genuity

Sep 29, 2025 04:16AM Artivion Inc. (AORT) PT Raised to $46 at Stifel

Aug 22, 2025 06:58AM Artivion Inc. (AORT) PT Raised to $50 at Needham

Aug 13, 2025 06:38AM Ladenburg Thalmann Downgrades Artivion Inc. (AORT) to Neutral

Aug 8, 2025 10:02AM Artivion Inc. (AORT) PT Raised to $40 at Stifel

Aug 8, 2025 07:09AM Artivion Inc. (AORT) PT Raised to $45 at Needham

Aug 8, 2025 06:44AM Artivion Inc. (AORT) PT Raised to $41 at Canaccord Genuity

Aug 8, 2025 06:05AM Artivion Inc. (AORT) PT Lowered to $40 at Oppenheimer

Aug 8, 2025 06:03AM Artivion Inc. (AORT) PT Raised to $40 at Oppenheimer

Aug 8, 2025 04:11AM Artivion Inc. (AORT) PT Raised to $42 at Citizens JMP

Aug 7, 2025 04:08PM Artivion (AORT) Tops Q2 EPS by 24c ; Offers Guidance

Aug 6, 2025 09:44AM Artivion Inc. (AORT) PT Raised to $36 at Stifel

Jul 28, 2025 04:17AM Citizens JMP Reiterates Market Outperform Rating on Artivion Inc. (AORT)

Jun 17, 2025 05:06AM Canaccord Genuity Starts Artivion Inc. (AORT) at Buy

May 14, 2025 04:01PM Artivion (AORT) Announces Agreements to Exchange $95M in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 6, 2025 08:53AM Citizens JMP Reiterates Market Outperform Rating on Artivion Inc. (AORT)

May 6, 2025 04:46AM Stifel Reiterates Buy Rating on Artivion Inc. (AORT)

May 5, 2025 04:08PM Artivion (AORT) Tops Q1 EPS by 6c ; Offers Guidance

Feb 25, 2025 09:47AM Artivion Inc. (AORT) PT Lowered to $30 at Stifel

Feb 25, 2025 06:11AM Artivion Inc. (AORT) PT Lowered to $32 at Needham

Feb 25, 2025 04:09AM Citizens JMP Reiterates Market Outperform Rating on Artivion Inc. (AORT)

Feb 24, 2025 04:08PM Artivion (AORT) Tops Q4 EPS by 6c, provides guidance

Jan 27, 2025 10:45AM Oppenheimer Reiterates Outperform Rating on Artivion Inc. (AORT)

Jan 27, 2025 10:45AM Oppenheimer Reiterates Outperform Rating on Artivion Inc. (AORT)

Dec 9, 2024 08:04AM Artivion (AORT) Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

Dec 9, 2024 07:09AM Artivion (AORT) is taking measures to address a cybersecurity incident

Nov 8, 2024 08:26AM Artivion Inc. (AORT) PT Raised to $34 at Needham

Nov 7, 2024 04:23PM Artivion (AORT) Tops Q3 EPS by 18c, Beats on Revenue; Offers FY24 Revenue Guidance

Oct 23, 2024 03:34AM JMP Securities Starts Artivion Inc. (AORT) at Market Outperform

Oct 10, 2024 04:11PM Artivion (AORT) Announces Presentation of Late-Breaking Clinical Data at EACTS

Sep 27, 2024 06:00AM Needham Reiterates Buy Rating on Artivion Inc. (AORT)

Aug 9, 2024 07:54AM Artivion Inc. (AORT) PT Raised to $30 at Oppenheimer

Aug 8, 2024 04:37PM Artivion (AORT) Tops Q2 EPS by 16c ; Offers Guidance

Jul 2, 2024 08:50AM Artivion Inc. (AORT) PT Raised to $30 at Lake Street Capital Markets

Jul 1, 2024 04:08PM Artivion (AORT) Amends Agreements with Endospan